Context:
Maple syrup urine disease (MSUD) is a rare genetic disorder that prevents the body from processing certain amino acids. This leads to a characteristic odor of maple syrup in the urine. Hope has been renewed for Maple Syrup Urine Disease (MSUD) with the introduction of a new gene therapy.
Key Findings
- Successful Gene Replacement Therapy for MSUD
- Scientists developed gene therapy using an adeno associated viral vector to deliver functional copies of the BCKDHA and BCKDHB genes.
- This prevented the recurrence of fatal neurological signs in animals that had received the therapy.
- Breakthroughs in the Animal Trials
- Mice Trials: Therapy had action in knockout cells, was safe in wild type mice, and prevented death in genetically deficient mice.
- Cow Calf Experiment
- A newborn calf with MSUD received the therapy and grew normally for two years. The animal was able to transition to a high protein diet, unlike untreated MSUD cases.
Meaning for the Human Patient
- Current Problems
- Patients with MSUD either need strict low protein diets or liver transplantation to avoid life-threatening complications.
- Application for Humans
- The therapy might provide a less invasive and sustainable treatment for MSUD patients harboring mutations in BCKDHA or BCKDHB.
Long-term Assessment: Assess how the therapy affects BCKDH levels in the brain.
Cognition and Behavior Assessment: Check for neurological and cognitive advantages for longer periods.
Source: The Hindu
